Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Morphologic, Histologic Features, Clinical and Prognostic Implications of Novel Discoveries
Keywords:
Chronic Lymphocytic Leukemia, Morphologic, Clinical and Prognostic Implications.Abstract
Two prevalent low-grade, typically indolent B-cell
lymphoproliferative disorders are chronic lymphocytic leukaemia (CLL) and
small lymphocytic lymphoma (SLL), which are lymph node tumours. Both
SLL and CLL can develop from preexisting low-level monoclonal or
oligoclonal B-cell expansions; unlike other B-cell malignancies, they do not
exhibit the hallmark reciprocal chromosomal translocations. At now, CLL/SLL
offers the most promising model among haematopoietic tumours for the
application of prognostic and predictive indicators to influence treatment
decisions. Additionally, CLL/SLL exemplifies the integration of serum
biomarkers with tumour immunophenotyping (FC, IHC), genomic profiling
(FISH, etc.), and tumour histogenesis studies (Ig gene expression mutation
status, for example) as a case study. Similar to chronic lymphocytic leukaemia
(CML) and acute lymphoblastic leukaemia (ALL), chemotherapy-induced
disease (CRD) monitoring by FC is now standard practice in post-treatment
care
Downloads

Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Current Clinical and Medical Education